Instadose Pharma Corp Net Income
| INSD Stock | USD 0.0001 0.00 0.00% |
Instadose Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Instadose Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Instadose Pharma's valuation are provided below:Instadose Pharma Corp does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Instadose | Build AI portfolio with Instadose Stock |
Will Pharmaceuticals sector continue expanding? Could Instadose diversify its offerings? Factors like these will boost the valuation of Instadose Pharma. Market participants price Instadose higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Instadose Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Instadose Pharma Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Instadose Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Instadose Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Instadose Pharma's market price signifies the transaction level at which participants voluntarily complete trades.
Instadose Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Instadose Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Instadose Pharma.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Instadose Pharma on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Instadose Pharma Corp or generate 0.0% return on investment in Instadose Pharma over 90 days. Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid... More
Instadose Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Instadose Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Instadose Pharma Corp upside and downside potential and time the market with a certain degree of confidence.
Instadose Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Instadose Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Instadose Pharma's standard deviation. In reality, there are many statistical measures that can use Instadose Pharma historical prices to predict the future Instadose Pharma's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Instadose Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Instadose Pharma Corp Backtested Returns
We have found three technical indicators for Instadose Pharma Corp, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Instadose Pharma are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Instadose Pharma Corp has perfect predictability. Overlapping area represents the amount of predictability between Instadose Pharma time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Instadose Pharma Corp price movement. The serial correlation of 1.0 indicates that 100.0% of current Instadose Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Instadose Pharma Corp reported net income of 462.02 K. This is 99.86% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 99.92% higher than that of the company.
Instadose Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Instadose Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Instadose Pharma could also be used in its relative valuation, which is a method of valuing Instadose Pharma by comparing valuation metrics of similar companies.Instadose Pharma is currently under evaluation in net income category among its peers.
Fund Asset Allocation for Instadose Pharma
The fund invests 99.58% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides Instadose Pharma's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors for a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will manage securities in the fund's portfolio as market conditions and the fund's objectives change.
Instadose Fundamentals
| Return On Asset | -694.06 | ||||
| Current Valuation | 757.11 K | ||||
| Shares Outstanding | 531.93 M | ||||
| Shares Owned By Insiders | 3.11 % | ||||
| Price To Book | 0.02 X | ||||
| EBITDA | (462.02 K) | ||||
| Net Income | 462.02 K | ||||
| Cash And Equivalents | 5.33 K | ||||
| Total Debt | 162.3 K | ||||
| Debt To Equity | 0.01 % | ||||
| Book Value Per Share | 0.05 X | ||||
| Cash Flow From Operations | (65) | ||||
| Beta | -827.91 | ||||
| Market Capitalization | 53.19 K | ||||
| Retained Earnings | (568.38 K) | ||||
| Working Capital | (162.3 K) | ||||
| Year To Date Return | 9.44 % | ||||
| One Year Return | 9.44 % | ||||
| Equity Positions Weight | 99.58 % |
About Instadose Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Instadose Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Instadose Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Instadose Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:Check out You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Pharmaceuticals sector continue expanding? Could Instadose diversify its offerings? Factors like these will boost the valuation of Instadose Pharma. Market participants price Instadose higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Instadose Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Instadose Pharma Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Instadose Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Instadose Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Instadose Pharma's market price signifies the transaction level at which participants voluntarily complete trades.